Catalytically inactive heme oxygenase-2 mutant is cytoprotective

被引:29
作者
Kim, YS [1 ]
Doré, S [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, ACCM Dept,Neuro Res Div, Baltimore, MD 21205 USA
关键词
hemin; bilirubin; carbon monoxide; hydrogen peroxide; iron;
D O I
10.1016/j.freeradbiomed.2005.04.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heme oxygenase (HO) catalyzes the rate-limiting step in heme degradation, producing iron, carbon monoxide, and bilirubin/biliverdin. HO consists of two isozymes: HO-1, which is an oxidative stress-response protein, and HO-2, which is constitutively expressed. HO-2 accounts for most HO activity within the nervous system. Its posttranslational modifications and/or interactions with other proteins make HO-2 a unique regulator of cellular homeostasis. Our previous results revealed that brain infarct volume was enlarged in HO-2 knockout mice. A similar neuroprotective role of HO-2 was shown using primary cortical neurons. To better understand the neuroprotective mechanism of HO-2, we used a catalytically inactive mutant, HO-2(H45A), and investigated its cellular effects in response to hemin and hydrogen peroxide-induced cytotoxicity. We observed that HO-2(WT) overexpression in the HEK293 cell lines became less sensitive to hemin, whereas the inactive mutant HO-2(H45A) was more sensitive to hemin as compared to control. Interestingly, HO-2(WT)- and HO-2(H45A)-overexpressing cells were both protected against H2O2-induced oxidative stress and had less oxidatively modified proteins as compared to control cells. These data indicate that when HO-2 cannot metabolize the prooxidant heme, more cytotoxicity is found, whereas, interestingly, the catalytically inactive HO-2(H45A) was also able to protect cells against oxidative stress injury. These results suggest the multiplicity of action of the HO-2 protein itself. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:558 / 564
页数:7
相关论文
共 31 条
[21]   Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway [J].
Otterbein, LE ;
Bach, FH ;
Alam, J ;
Soares, M ;
Lu, HT ;
Wysk, M ;
Davis, RJ ;
Flavell, RA ;
Choi, AMK .
NATURE MEDICINE, 2000, 6 (04) :422-428
[22]   ON THE MECHANISM OF THE CHEMICAL AND ENZYMATIC OXYGENATIONS OF ALPHA-OXYPROTOHEMIN-IX TO FE.BILIVERDIN-IX-ALPHA [J].
SANO, S ;
SANO, T ;
MORISHIMA, I ;
SHIRO, Y ;
MAEDA, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (03) :531-535
[23]   Why heme needs to be degraded to iron, biliverdin IXα, and carbon monoxide? [J].
Sassa, S .
ANTIOXIDANTS & REDOX SIGNALING, 2004, 6 (05) :819-824
[24]   CLONING AND EXPRESSION OF CDNA FOR RAT HEME OXYGENASE [J].
SHIBAHARA, S ;
MULLER, R ;
TAGUCHI, H ;
YOSHIDA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (23) :7865-7869
[25]   Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease [J].
Takahashi, M ;
Doré, S ;
Ferris, CD ;
Tomita, T ;
Sawa, A ;
Wolosker, H ;
Borchelt, DR ;
Iwatsubo, T ;
Kim, SH ;
Thinakaran, G ;
Sisodia, SS ;
Snyder, SH .
NEURON, 2000, 28 (02) :461-473
[26]   Hemoglobin and iron-evoked oxidative stress in the brain:: Protection by bile pigments, manganese and S-nitrosoglutathione [J].
Van Bergen, P ;
Rauhala, P ;
Spooner, CM ;
Chiueh, CC .
FREE RADICAL RESEARCH, 1999, 31 (06) :631-640
[27]  
VILE GF, 1993, J BIOL CHEM, V268, P14678
[28]  
Vreman HJ, 1998, CAN J PHYSIOL PHARM, V76, P1057
[29]   Interaction between heme oxygenase-1 and-2 proteins [J].
Weng, YH ;
Yang, G ;
Weiss, S ;
Dennery, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (51) :50999-51005
[30]   THE CYTOPROTECTIVE EFFECTS OF BILIRUBIN AND BILIVERDIN ON RAT HEPATOCYTES AND HUMAN ERYTHROCYTES AND THE IMPACT OF ALBUMIN [J].
WU, TW ;
CAREY, D ;
WU, J ;
SUGIYAMA, H .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1991, 69 (12) :828-834